Suppr超能文献

胰腺炎患者血清和尿液中辅脂酶的检测

Detection of colipase in serum and urine of pancreatitis patients.

作者信息

Junge W, Leybold K

出版信息

Clin Chim Acta. 1982 Aug 18;123(3):293-302. doi: 10.1016/0009-8981(82)90174-7.

Abstract

Colipase, like other pancreatic proteins, is liberated into the circulation in acute pancreatitis. Its concentration was measured in serum by a turbidimetric and in urine by a titrimetric method. The principle of both assays is based on the reactivation of bile acid inhibited, pure human pancreatic lipase by colipase. Whereas in healthy individuals colipase was found neither in serum nor urine (detection limit approximately 6.5 micrograms/1), a wide concentration range was observed in 29 patients with acute pancreatitis. Urine values varied between 3.8 and 7121 micrograms colipase/g creatinine; in serum levels up to 664 micrograms/1 were found. There was no correlation with serum lipase activity: On a molar basis, the ratio of serum colipase to serum lipase ranged between less than 0.04 and 2.14, but was below 1 in most sera. Colipase is rapidly removed from the circulation by glomerular filtration, its elimination rate from serum being more than twice as fast as that of lipase. This results in a constant decrease of the colipase/lipase ratio during the course of the disease. Probably determination of colipase is of no direct diagnostic value in pancreatic disorders, but our findings are of considerable significance for the measurement of serum lipase in the presence of bile acids, particularly with regard to turbidimetric assays. We conclude that lipase activity values obtained by these methods are mainly dependent on the degree of saturation of the enzyme with its cofactor and not on the true lipase concentration.

摘要

与其他胰腺蛋白一样,共脂肪酶在急性胰腺炎时释放入血循环。采用比浊法测定血清中共脂肪酶浓度,采用滴定法测定尿中共脂肪酶浓度。两种检测方法的原理均基于共脂肪酶对胆汁酸抑制的纯人胰腺脂肪酶的重新激活作用。健康个体的血清和尿液中均未检测到共脂肪酶(检测限约为6.5微克/升),而在29例急性胰腺炎患者中观察到其浓度范围较宽。尿中值在3.8至7121微克共脂肪酶/克肌酐之间;血清中水平高达664微克/升。共脂肪酶与血清脂肪酶活性无相关性:以摩尔计,血清共脂肪酶与血清脂肪酶的比值在小于0.04至2.14之间,但大多数血清中该比值低于1。共脂肪酶通过肾小球滤过迅速从血循环中清除,其从血清中的清除率比脂肪酶快两倍多。这导致在疾病过程中共脂肪酶/脂肪酶比值持续下降。共脂肪酶测定在胰腺疾病中可能没有直接诊断价值,但我们的发现对于在存在胆汁酸的情况下测定血清脂肪酶具有重要意义,特别是对比浊法而言。我们得出结论,通过这些方法获得的脂肪酶活性值主要取决于酶与其辅因子的饱和程度,而不是真正的脂肪酶浓度。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验